A library of peptide research, organized by hub.
Five subject hubs: peptide science fundamentals, analytical quality, evidence standards, compound profiles by pathway, and regulatory science. Every article separates molecule-level evidence from product-level status.
Emerging Trends
Frontier areas: mitochondrial-derived peptides, senolytics, AMPs, BBB shuttles, oncology, and rare-disease research.
Can Peptides Cross the Blood-Brain Barrier?
Cell penetration is not brain penetration. The correct question is how much intact material reaches which compartment.
Read articlePeptide Immunogenicity: Why Small Molecules Can Still Trigger Immune Responses
Small peptide should never be used as shorthand for non-immunogenic.
Read articleWhat the 2025 FDA Peptide Approval Landscape Tells Us
Modern peptide programs solve delivery and quality, not just receptor potency.
Read articlePeptide Therapeutics in Rare Disease Research
Rare-disease peptide research is a model of precision: clear biology, tightly defined materials, focused evidence.
Read articlePeptides in Oncology: Targeting, Imaging, and Delivery
Precision tools whose value depends on target validation, delivery, and product characterization.
Read articlePeptide Vaccines and Targeted Delivery Platforms
Platforms make peptides part of a multicomponent system whose performance depends on every linkage.
Read articleAntimicrobial Peptides and the Challenge of Therapeutic Selectivity
Selectivity, not raw antimicrobial potency, is the primary endpoint for serious AMP research.
Read articleSenolytic Peptides: What the Field Is Actually Testing
Selective biology, not marketing language, is the field's most important question.
Read articleThe Rise of Mitochondrial-Derived Peptides
Endogenous biology, biomarker studies, and synthetic administration must remain clearly separated.
Read article